NCT00787436View on ClinicalTrials.gov

Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Gastrointestinal HemorrhagePortal Hypertension

Interventions

DRUG

Thalidomide

Medical therapy has been used to decrease upper gastrointestinal bleeding in cirrhotics Non Selective beta blockers have been shown to effectively decrease the portal venous pressure

Trial Locations (1)

44109

Cleveland Clinic Foundation, Cleveland